These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 36352227)

  • 1. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity.
    Xue R; Zhang Q; Cao Q; Kong R; Xiang X; Liu H; Feng M; Wang F; Cheng J; Li Z; Zhan Q; Deng M; Zhu J; Zhang Z; Zhang N
    Nature; 2022 Dec; 612(7938):141-147. PubMed ID: 36352227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular dynamics in tumour microenvironment along with lung cancer progression underscore spatial and evolutionary heterogeneity of neutrophil.
    Peng H; Wu X; Liu S; He M; Tang C; Wen Y; Xie C; Zhong R; Li C; Xiong S; Liu J; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jul; 13(7):e1340. PubMed ID: 37491740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
    Wang L; Liu Y; Dai Y; Tang X; Yin T; Wang C; Wang T; Dong L; Shi M; Qin J; Xue M; Cao Y; Liu J; Liu P; Huang J; Wen C; Zhang J; Xu Z; Bai F; Deng X; Peng C; Chen H; Jiang L; Chen S; Shen B
    Gut; 2023 May; 72(5):958-971. PubMed ID: 35688610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
    Shi J; Li J; Wang H; Li X; Wang Q; Zhao C; Cheng L; Han R; Chen P; Guo H; Tang Z; Zhou C; Zhang Z; Wu F
    Lung Cancer (Auckl); 2023; 14():85-99. PubMed ID: 38025400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing neutrophil plasticity for HCC immunotherapy.
    Ramon-Gil E; Geh D; Leslie J
    Essays Biochem; 2023 Sep; 67(6):941-955. PubMed ID: 37534829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer.
    Yang M; Zhang G; Wang Y; He M; Xu Q; Lu J; Liu H; Xu C
    Br J Cancer; 2020 Oct; 123(9):1404-1416. PubMed ID: 32778818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis.
    Tang D; Zhang D; Heng Y; Zhu XK; Lin HQ; Zhou J; Tao L; Lu LM
    J Inflamm Res; 2022; 15():1079-1097. PubMed ID: 35210813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil diversity and plasticity in tumour progression and therapy.
    Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
    Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFIT1‚ÄČ+‚ÄČneutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC).
    Liu YJ; Li JP; Han M; Li JX; Ye QW; Lin ST; Zhou JY; Liu SL; Zou X
    J Transl Med; 2024 Jun; 22(1):580. PubMed ID: 38898490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Tian S; Chu Y; Hu J; Ding X; Liu Z; Fu D; Yuan Y; Deng Y; Wang G; Wang L; Wang Z
    Gut; 2022 Dec; 71(12):2489-2501. PubMed ID: 35086885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy.
    Wu Q; Mao H; Jiang Z; Tang D
    Immunology; 2024 Jul; 172(3):343-361. PubMed ID: 38402904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance.
    Zhang D; Zhou J; Tang D; Zhou L; Chou L; Chou KY; Tao L; Lu LM
    Clin Immunol; 2017 Feb; 175():34-40. PubMed ID: 27876461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
    Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
    Front Immunol; 2019; 10():2155. PubMed ID: 31616408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-associated neutrophils in patients with cancer.
    Shaul ME; Fridlender ZG
    Nat Rev Clin Oncol; 2019 Oct; 16(10):601-620. PubMed ID: 31160735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using macrophage activation to augment immunotherapy of established tumours.
    Fridlender ZG; Jassar A; Mishalian I; Wang LC; Kapoor V; Cheng G; Sun J; Singhal S; Levy L; Albelda SM
    Br J Cancer; 2013 Apr; 108(6):1288-97. PubMed ID: 23481183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.
    Kim IS; Gao Y; Welte T; Wang H; Liu J; Janghorban M; Sheng K; Niu Y; Goldstein A; Zhao N; Bado I; Lo HC; Toneff MJ; Nguyen T; Bu W; Jiang W; Arnold J; Gu F; He J; Jebakumar D; Walker K; Li Y; Mo Q; Westbrook TF; Zong C; Rao A; Sreekumar A; Rosen JM; Zhang XH
    Nat Cell Biol; 2019 Sep; 21(9):1113-1126. PubMed ID: 31451770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.